Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels.
Fibrates are activators of peroxisome proliferator-activated receptor (PPAR) α. Pretreatment with fibrates has been shown to protect brain against ischemia in mice. We hypothesized that fibrates elevate superoxide dismutase (SOD) levels in the brain microvessels (BMVs). BMVs were isolated from male C57BL/6 and PPARα null mice that had been treated with fenofibrate or gemfibrozil for 7 days. To examine the effect of discontinuation of fenofibrate, another animal group treated with fenofibrate was examined on post-discontinuation day 3 (D-3). To examine whether SOD elevations attenuate oxidative stress in the ischemic brain, separate animals treated with fenofibrate for 7 days were subjected to 60 minutes of focal ischemia on post-discontinuation day 0 (D-0) or D-3. Fenofibrate (30 mg/kg) increased mRNA levels of all three isoforms of SOD and activity level in BMV on D-0, but these effects were not detected on D-3. The elevations were not detected in PPARα null mice. SOD levels were also elevated by gemfibrozil (30 mg/kg). Fenofibrate significantly reduced superoxide production and protein oxidation in the ischemic brain at 30 minutes after reperfusion. Fenofibrate reduced infarct size measured at 24 hours after reperfusion on D-0; however, the infarct reduction was not seen when ischemia was induced on D-3. These findings suggest that fibrates elevate SOD in BMV through PPARα, which contributes to the infarct reduction, at least in part. Further studies are needed to establish the link between the SOD elevations and the brain protection by fibrates against ischemia.
Wang
Guangming
G
Department of Neurobiology, Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Liu
Xiaowei
X
Guo
Qingmin
Q
Namura
Shobu
S
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000201:enzymology / Q000503:physiopathology; D002545:Brain Ischemia / Q000503:physiopathology; D011345:Fenofibrate / Q000494:pharmacology*; D015248:Gemfibrozil / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D055806:Microvessels / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects; D047495:PPAR gamma / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013482:Superoxide Dismutase / Q000096:biosynthesis*
D018696:Neuroprotective Agents; D047495:PPAR gamma; D012333:RNA, Messenger; D013482:Superoxide Dismutase; D015248:Gemfibrozil; D011345:Fenofibrate
Stroke. 2006 Oct;37(10):2640-3
16946153
J Neurosci. 2003 Jul 16;23(15):6264-71
12867511
Neurochem Int. 1985;7(1):1-25
20492893
Mutat Res. 2000 Mar 17;448(2):121-38
10725467
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11158-62
1763030
J Clin Invest. 2002 Mar;109(6):817-26
11901190
Stroke. 2007 Dec;38(12):3193-7
17962596
Stroke. 2009 Jul;40(7):2512-8
19461023
Gene. 1999 Jun 24;234(1):87-91
10393242
Nature. 2000 May 25;405(6785):421-4
10839530
J Biol Chem. 2003 Jan 24;278(4):2403-10
12441342
Lancet. 1999 Jan 16;353(9148):209-10
9923885
Pediatr Res. 1993 Oct;34(4):530-7
8255689
J Cereb Blood Flow Metab. 2010 Jan;30(1):70-8
19724288
Inflamm Res. 2000 Oct;49(10):497-505
11089900
Stroke. 2009 Apr;40(4):1365-72
19228852
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620-4
2154753
Nature. 1998 Jun 25;393(6687):790-3
9655393
Curr Neurovasc Res. 2009 Aug;6(3):181-93
19534718
Stroke. 1997 Feb;28(2):448-51; discussion 451-2
9040704
Mol Cell Biol. 1995 Jun;15(6):3012-22
7539101
Brain Res. 2009 Jul 7;1279:121-30
19427843
Biochem Biophys Res Commun. 2002 Aug 2;295(5):1052-6
12135600
Mol Pharmacol. 2009 Sep;76(3):588-95
19528198
Trends Neurosci. 1997 Mar;20(3):132-9
9061868
Nature. 1990 Oct 18;347(6294):645-50
2129546
J Lipid Res. 2006 Jul;47(7):1583-7
16585784
Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1367-73
15166009
Am J Physiol. 1992 Nov;263(5 Pt 2):H1356-62
1332509
Neurosci Lett. 2003 Dec 11;352(3):203-6
14625020
Nature. 1962 Jun 9;194:948-9
13921051
J Neurosci. 1998 Jan 1;18(1):205-13
9412501
Adv Enzymol Relat Areas Mol Biol. 1986;58:61-97
3521218
Int J Dev Neurosci. 2004 Jun;22(4):225-30
15245758
Biochem Pharmacol. 1999 Sep 15;58(6):1025-33
10509755
Stroke. 2008 Jul;39(7):2099-104
18436885
J Clin Invest. 2003 Apr;111(8):1201-9
12697739
Stroke. 2002 Feb;33(2):600-5
11823676
Vascul Pharmacol. 2009 Nov-Dec;51(5-6):323-30
19732852
Neuroscience. 1999 Jan;88(1):185-91
10051199